Influenza model
Nova’s influenza model accounts for the interplay between a viral infection and vaccination. It describes the key pathways and biomarkers influencing vaccine efficacy…
Nova’s influenza model accounts for the interplay between a viral infection and vaccination. It describes the key pathways and biomarkers influencing vaccine efficacy, including antigenic drift, strain, immunogenicity, immunosenescence and timing of vaccination.
Summary
- Model description (Influenza)
- Drugs that can be tested
- Populations of interest
- Possible clinical endpoints
- Biological submodels
-
Early insights to optimize your trial design
- Vaccination
- Patient selection
- Vaccine strain
Download
Flyer
Get your questions answered by downloading the free pdf and learn more about your therapeutic area of interest!